Results

1–3 of 3 results for Rajiv Anand

Subretinal AGTC-501 Gene Therapy for XLRP: 12-Month Interim Safety & Efficacy Results of the Randomized Controlled Multicenter Phase 2 Skyline Trial
Rajiv Anand, MD, FRCS, FASRS
Annual Meeting Talks
2024
Vitrectomy and ILM peeling in Optic nerve pit (ONP) associated Retinal detachment
Rajiv Anand, MD, FRCS, FASRS
On Demand Cases, Courses, and Papers
2019
Ranibizumab for Radiation Retinopathy (RRR) A Prospective, Multicenter Trial of Monthly Versus PRN Dosing for Radiation Retinopathy-Related Macular Edema
Rajiv Anand, MD, FRCS, FASRS
Annual Meeting Talks
2018